Reuters logo
BRIEF-Merck KGaA and Pfizer: CHMP recommends approval of avelumab
July 21, 2017 / 11:37 AM / 4 months ago

BRIEF-Merck KGaA and Pfizer: CHMP recommends approval of avelumab

July 21 (Reuters) - MERCK KGAA:

* EMA’S CHMP ISSUES POSITIVE OPINION FOR AVELUMAB FOR THE TREATMENT OF METASTATIC MERKEL CELL CARCINOMA

* EUROPEAN COMMISSION WILL NOW REVIEW THE CHMP’S RECOMMENDATION, WITH A DECISION EXPECTED IN THE THIRD QUARTER OF 2017‍​ Source text - bit.ly/2twp3SS Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below